In children, deaths were reduced from 108 per 1000 with quinine to 83 with artesunate. – ‘There is now enough evidence to be sure, these results in adults and children,’said Peter Olumese of the WHO Global Malaria Programme. ‘Intravenous artesunate is now treatment of choice treatment of choice for adults and children with severe malaria anywhere in the world. ‘.. The researchers of the review of artesunate, multicenter studylti-center study of African children Lancet Lancet in 2010, to update the existing 8 trials. The review now includes a total of 1664 adults and 5765 children, from a variety of settings in Africa and Asia. According to the results under artesunate reduces the risk of death by 39 percent in adults and 24 percent in children compared to quinine.
Severe malaria occurs when the disease affects the function of vital organs. It is rare with cerebral malaria, which affects the brain and can lead to long-term disability associated. More than a million people die each year from severe malaria, most of them in sub-Saharan Africa. Artesunate was recommended as the preferred treatment for adults with severe malaria by the World Health Organization in 2006, but is not sufficient evidence at the time to recommend a change from the standard treatment of quinine in children.With courtesy They can whole Kaiser Daily HealthPolicyMonitor see Reports search the archives or sign up for mail notification in Kaiser Daily Health policy coverage strongly supported kaiser network. A free service from the Henry J. Releases. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Partner of research:of by which Canadian Language and Literacy Research Network, the Natural Sciences and Engineering Research Council and the U.S. The National Institutes of Health. About the survey:.